The intestinal microenvironment and functional gastrointestinal disorders

Gastroenterology

Volumn 150, Issue 6, 2016, Pages 1305-1318.e8

  Barbara, Giovanni ^a   Feinle Bisset, Christine ^b   Ghoshal, Uday C ^c   Santos, Javier ^d   Vanner, Stepen J ^e   Vergnolle, Nathalie ^f,g   Zoetendal, Erwin G ^h   Quigley, Eamonn M ⁱ  

^a UNIVERSITY OF BOLOGNA   (Italy)

^b UNIVERSITY OF ADELAIDE   (Australia)

^c SANJAY GANDHI POSTGRADUATE INSTITUTE OF MEDICAL SCIENCES   (India)

^d HOSPITAL UNIVERSITARI VALL D HEBRON   (Spain)

^e QUEEN S UNIVERSITY   (Canada)

^f INSERM   (France)

^g UMR 1220 TCEM (INRA ENITAB)   (France)

^h WAGENINGEN UNIVERSITY   (Netherlands)

ⁱ HOUSTON METHODIST HOSPITAL   (United States)

Author keywords

Bile Acids; Food; Functional Dyspepsia; Immune System; Irritable Bowel Syndrome; Microbiota; Serotonin

Indexed keywords

BILE ACID; FAT; PROBIOTIC AGENT; SEROTONIN RECEPTOR;

ARTICLE; CELIAC DISEASE; CHEMICAL STRUCTURE; CLINICAL OBSERVATION; CLINICAL STUDY; DIET; DIGESTIVE SYSTEM FUNCTION DISORDER; DYSPEPSIA; EVIDENCE BASED PRACTICE; FAT INTAKE; FOOD ALLERGY; HUMAN; INTESTINE FLORA; INTESTINE MUCOSA PERMEABILITY; IRRITABLE COLON; LIFESTYLE; MICROBIAL METABOLISM; MICROENVIRONMENT; MUCOSAL IMMUNITY; PATHOGENESIS; PRIORITY JOURNAL; PROVOCATION; SENSORIMOTOR FUNCTION; SEROTONIN METABOLISM; SYMPTOM; WHEAT;

EID: 84964779646     PISSN: 00165085     EISSN: 15280012     Source Type: Journal    
DOI: 10.1053/j.gastro.2016.02.028     Document Type: Article

References (120)

1. G.T. Stewart Post-dysenteric colitis Br Med J 1 1950 405 409
2. A.N. Pilichiewicz, M. Horowitz, G.J. Holtmann, and et al. Relationship between symptoms and dietary patterns in patients with functional dyspepsia Clin Gastroenterol Hepatol 7 2009 317 322
3. C. Feinle-Bisset, and F. Azpiroz Dietary and lifestyle factors in functional dyspepsia Nat Rev Gastroenterol Hepatol 10 2013 150 157
4. L. Bohn, S. Storsrud, H. Tornblom, and et al. Self-reported food-related gastrointestinal symptoms in IBS are common and associated with more severe symptoms and reduced quality of life Am J Gastroenterol 108 2013 634 641
5. M. El-Salhy, H. Ostgaard, D. Gundersen, and et al. The role of diet in the pathogenesis and management of irritable bowel syndrome (review) Int J Mol Med 29 2012 723 731
6. S.J. Shepherd, F.C. Parker, J.G. Muir, and et al. Dietary triggers of abdominal symptoms in patients with irritable bowel syndrome: randomized placebo-controlled evidence Clin Gastroenterol Hepatol 6 2008 765 771
7. J.R. Biesiekierski, S.L. Peters, E.D. Newnham, and et al. No effects of gluten in patients with self-reported non-celiac gluten sensitivity after dietary reduction of fermentable, poorly absorbed, short-chain carbohydrates Gastroenterology 145 2013 320 328 e1-e3
8. S. Eswaran, A. Goel, and W.D. Chey What role does wheat play in the symptoms of irritable bowel syndrome? Gastroenterol Hepatol (N Y) 9 2013 85 91
9. A. Carroccio, A. D'Alcamo, F. Cavataio, and et al. High proportions of people with nonceliac wheat sensitivity have autoimmune disease or antinuclear antibodies Gastroenterology 149 2015 596 603 e1
10. N. Cenac, T. Bautzova, P. Le Faouder, and et al. Quantification and potential functions of endogenous agonists of transient receptor potential channels in patients with irritable bowel syndrome Gastroenterology 149 2015 433 444 e7
11. E.P. Halmos, V.A. Power, S.J. Shepherd, and et al. A diet low in FODMAPs reduces symptoms of irritable bowel syndrome Gastroenterology 146 2014 67 75 e5
12. E.P. Halmos, C.T. Christophersen, A.R. Bird, and et al. Diets that differ in their FODMAP content alter the colonic luminal microenvironment Gut 64 2015 93 100
13. J.R. Biesiekierski, E.D. Newnham, P.M. Irving, and et al. Gluten causes gastrointestinal symptoms in subjects without celiac disease: a double-blind randomized placebo-controlled trial Am J Gastroenterol 106 2011 508 514 quiz 515
14. M.I. Vazquez-Roque, M. Camilleri, T. Smyrk, and et al. A controlled trial of gluten-free diet in patients with irritable bowel syndrome-diarrhea: effects on bowel frequency and intestinal function Gastroenterology 144 2013 903 911 e3
15. L. Bohn, S. Storsrud, T. Liljebo, and et al. Diet low in FODMAPs reduces symptoms of irritable bowel syndrome as well as traditional dietary advice: a randomized controlled trial Gastroenterology 149 2015 1399 1407 e2
16. T. Yatsunenko, F.E. Rey, M.J. Manary, and et al. Human gut microbiome viewed across age and geography Nature 486 2012 222 227
17. A. Salonen, and W.M. de Vos Impact of diet on human intestinal microbiota and health Annu Rev Food Sci Technol 5 2014 239 262
18. E.G. Zoetendal, and W.M. de Vos Effect of diet on the intestinal microbiota and its activity Curr Opin Gastroenterol 30 2014 189 195
19. H.J. Flint, K.P. Scott, P. Louis, and et al. The role of the gut microbiota in nutrition and health Nat Rev Gastroenterol Hepatol 9 2012 577 589
20. M. Vital, A.C. Howe, and J.M. Tiedje Revealing the bacterial butyrate synthesis pathways by analyzing (meta)genomic data MBio 5 2014 e00889
21. T.L. Miller, and M.J. Wolin Pathways of acetate, propionate, and butyrate formation by the human fecal microbial flora Appl Environ Microbiol 62 1996 1589 1592
22. T. Banasiewicz, L. Krokowicz, Z. Stojcev, and et al. Microencapsulated sodium butyrate reduces the frequency of abdominal pain in patients with irritable bowel syndrome Colorectal Dis 15 2013 204 209
23. P. Kannampalli, R. Shaker, and J.N. Sengupta Colonic butyrate- algesic or analgesic? Neurogastroenterol Motil 23 2011 975 979
24. C. Tana, Y. Umesaki, A. Imaoka, and et al. Altered profiles of intestinal microbiota and organic acids may be the origin of symptoms in irritable bowel syndrome Neurogastroenterol Motil 22 2010 512 519 e114-e115
25. M. Pimentel, H.C. Lin, P. Enayati, and et al. Methane, a gas produced by enteric bacteria, slows intestinal transit and augments small intestinal contractile activity Am J Physiol Gastrointest Liver Physiol 290 2006 G1089 G1095
26. D. Cloarec, F. Bornet, S. Gouilloud, and et al. Breath hydrogen response to lactulose in healthy subjects: relationship to methane producing status Gut 31 1990 300 304
27. E.P. Nyangale, D.S. Mottram, and G.R. Gibson Gut microbial activity, implications for health and disease: the potential role of metabolite analysis J Proteome Res 11 2012 5573 5585
28. D. Tooth, K. Garsed, G. Singh, and et al. Characterisation of faecal protease activity in irritable bowel syndrome with diarrhoea: origin and effect of gut transit Gut 63 2014 753 760
29. A.P. Moreira, T.F. Texeira, A.B. Ferreira, and et al. Influence of a high-fat diet on gut microbiota, intestinal permeability and metabolic endotoxaemia Br J Nutr 108 2012 801 809
30. M. Simren, G. Barbara, H.J. Flint, and et al. Intestinal microbiota in functional bowel disorders: a Rome foundation report Gut 62 2013 159 176
31. H. Paula, M. Grover, S.L. Halder, and et al. Non-enteric infections, antibiotic use, and risk of development of functional gastrointestinal disorders Neurogastroenterol Motil 27 2015 1580 1586
32. A.C. Ford, E.M. Quigley, B.E. Lacy, and et al. Efficacy of prebiotics, probiotics, and synbiotics in irritable bowel syndrome and chronic idiopathic constipation: systematic review and meta-analysis Am J Gastroenterol 109 2014 1547 1561 quiz 1546, 1562
33. Y. Zhu, F. Li, and G.L. Guo Tissue-specific function of farnesoid X receptor in liver and intestine Pharmacol Res 63 2011 259 265
34. S.T. Odunsi-Shiyanbade, M. Camilleri, S. McKinzie, and et al. Effects of chenodeoxycholate and a bile acid sequestrant, colesevelam, on intestinal transit and bowel function Clin Gastroenterol Hepatol 8 2010 159 165
35. B.V. Jones, M. Begley, C. Hill, and et al. Functional and comparative metagenomic analysis of bile salt hydrolase activity in the human gut microbiome Proc Natl Acad Sci U S A 105 2008 13580 13585
36. A.F. Hofmann, and L. Eckmann How bile acids confer gut mucosal protection against bacteria Proc Natl Acad Sci U S A 103 2006 4333 4334
37. L. Wedlake, R. A'Hern, D. Russell, and et al. Systematic review: the prevalence of idiopathic bile acid malabsorption as diagnosed by SeHCAT scanning in patients with diarrhoea-predominant irritable bowel syndrome Aliment Pharmacol Ther 30 2009 707 717
38. M. Camilleri, M.I. Vazquez-Roque, P. Carlson, and et al. Association of bile acid receptor TGR5 variation and transit in health and lower functional gastrointestinal disorders Neurogastroenterol Motil 23 2011 995 999 e458
39. A. Bajor, K.A. Ung, L. Ohman, and et al. Indirect evidence for increased mechanosensitivity of jejunal secretomotor neurones in patients with idiopathic bile acid malabsorption Acta Physiol (Oxf) 197 2009 129 137
40. W.O. Kirwan, A.N. Smith, W.D. Mitchell, and et al. Bile acids and colonic motility in the rabbit and the human Gut 16 1975 894 902
41. R.N. Appleby, and J.R. Walters The role of bile acids in functional GI disorders Neurogastroenterol Motil 26 2014 1057 1069
42. J.R. Turner Intestinal mucosal barrier function in health and disease Nat Rev Immunol 9 2009 799 809
43. D. Gunzel, and A.S. Yu Claudins and the modulation of tight junction permeability Physiol Rev 93 2013 525 569
44. S. Tsukita, T. Katsuno, Y. Yamazaki, and et al. Roles of ZO-1 and ZO-2 in establishment of the belt-like adherens and tight junctions with paracellular permselective barrier function Ann N Y Acad Sci 1165 2009 44 52
45. J. Santos, E. Saperas, C. Nogueiras, and et al. Release of mast cell mediators into the jejunum by cold pain stress in humans Gastroenterology 114 1998 640 648
46. C. Alonso, M. Guilarte, M. Vicario, and et al. Maladaptive intestinal epithelial responses to life stress may predispose healthy women to gut mucosal inflammation Gastroenterology 135 2008 163 172 e1
47. C. Wallon, P.C. Yang, A.V. Keita, and et al. Corticotropin-releasing hormone (CRH) regulates macromolecular permeability via mast cells in normal human colonic biopsies in vitro Gut 57 2008 50 58
48. T. Vanuytsel, S. van Wanrooy, H. Vanheel, and et al. Psychological stress and corticotropin-releasing hormone increase intestinal permeability in humans by a mast cell-dependent mechanism Gut 63 2014 1293 1299
49. S.C. Bischoff, G. Barbara, W. Buurman, and et al. Intestinal permeability-a new target for disease prevention and therapy BMC Gastroenterol 14 2014 189
50. R.M. Patel, L.S. Myers, A.R. Kurundkar, and et al. Probiotic bacteria induce maturation of intestinal claudin 3 expression and barrier function Am J Pathol 180 2012 626 635
51. C. Blaschitz, and M. Raffatellu Th17 cytokines and the gut mucosal barrier J Clin Immunol 30 2010 196 203
52. M. El-Salhy, D. Gundersen, O.H. Gilja, and et al. Is irritable bowel syndrome an organic disorder? World J Gastroenterol 20 2014 384 400
53. L.J. Miller Gastrointestinal Hormones and Receptors 1999 Lippincott-Williams and Wilkins Philadelphia, Pa
54. J.B. Furness, L.R. Rivera, H.J. Cho, and et al. The gut as a sensory organ Nat Rev Gastroenterol Hepatol 10 2013 729 7240
55. F. De Ponti Pharmacology of serotonin: what a clinician should know Gut 53 2004 1520 1535
56. M. Pytliak, V. Vargova, V. Mechirova, and et al. Serotonin receptors - from molecular biology to clinical applications Physiol Res 60 2011 15 25
57. M.D. Gershon, and J. Tack The serotonin signaling system: from basic understanding to drug development for functional GI disorders Gastroenterology 132 2007 397 414
58. M.W. Hale, A. Shekhar, and C.A. Lowry Development by environment interactions controlling tryptophan hydroxylase expression J Chem Neuroanat 41 2011 219 226
59. M. Manocha, and W.I. Khan Serotonin and GI disorders: an update on clinical and experimental studies Clin Transl Gastroenterol 3 2012 e13
60. M.B. Hansen, and A.B. Witte The role of serotonin in intestinal luminal sensing and secretion Acta Physiol (Oxf) 193 2008 311 323
61. D. Keszthelyi, F.J. Troost, D.M. Jonkers, and et al. Decreased levels of kynurenic acid in the intestinal mucosa of IBS patients: relation to serotonin and psychological state J Psychosom Res 74 2013 501 504
62. T. Takahashi Mechanism of interdigestive migrating motor complex J Neurogastroenterol Motil 18 2012 246 257
63. A. Esmaili, S.F. Nazir, A. Borthakur, and et al. Enteropathogenic Escherichia coli infection inhibits intestinal serotonin transporter function and expression Gastroenterology 137 2009 2074 2083
64. A. Yeo, P. Boyd, S. Lumsden, and et al. Association between a functional polymorphism in the serotonin transporter gene and diarrhoea predominant irritable bowel syndrome in women Gut 53 2004 1452 1458
65. A.S. Chua, P.W. Keeling, and T.G. Dinan Role of cholecystokinin and central serotonergic receptors in functional dyspepsia World J Gastroenterol 12 2006 1329 1335
66. S. Kumar, P. Ranjan, B. Mittal, and et al. Serotonin transporter gene (SLC6A4) polymorphism in patients with irritable bowel syndrome and healthy controls J Gastrointestin Liver Dis 21 2012 31 38
67. Z.F. Zhang, Z.J. Duan, L.X. Wang, and et al. The serotonin transporter gene polymorphism (5-HTTLPR) and irritable bowel syndrome: a meta-analysis of 25 studies BMC Gastroenterol 14 2014 23
68. R. Spiller, and C. Lam An update on post-infectious irritable bowel syndrome: role of genetics, immune activation, serotonin and altered microbiome J Neurogastroenterol Motil 18 2012 258 268
69. C.K. Cheung, Y.Y. Lee, Y. Chan, and et al. Decreased basal and postprandial plasma serotonin levels in patients with functional dyspepsia Clin Gastroenterol Hepatol 11 2013 1125 1129
70. S.P. Dunlop, N.S. Coleman, E. Blackshaw, and et al. Abnormalities of 5-hydroxytryptamine metabolism in irritable bowel syndrome Clin Gastroenterol Hepatol 3 2005 349 357
71. S. Gonlachanvit, P. Fongkam, S. Wittayalertpanya, and et al. Red chili induces rectal hypersensitivity in healthy humans: possible role of 5HT-3 receptors on capsaicin-sensitive visceral nociceptive pathways Aliment Pharmacol Ther 26 2007 617 625
72. R.C. Spiller, D. Jenkins, J.P. Thornley, and et al. Increased rectal mucosal enteroendocrine cells, T lymphocytes, and increased gut permeability following acute Campylobacter enteritis and in post-dysenteric irritable bowel syndrome Gut 47 2000 804 811
73. C. Cremon, G. Carini, B. Wang, and et al. Intestinal serotonin release, sensory neuron activation, and abdominal pain in irritable bowel syndrome Am J Gastroenterol 106 2011 1290 1298
74. S. Foley, K. Garsed, G. Singh, and et al. Impaired uptake of serotonin by platelets from patients with irritable bowel syndrome correlates with duodenal immune activation Gastroenterology 140 2011 1434 1443 e1
75. M.M. Walker, N.J. Talley, M. Prabhakar, and et al. Duodenal mastocytosis, eosinophilia and intraepithelial lymphocytosis as possible disease markers in the irritable bowel syndrome and functional dyspepsia Aliment Pharmacol Ther 29 2009 765 773
76. S. Fukudo, Y. Kinoshita, T. Okumura, and et al. Ramosetron reduces symptoms of irritable bowel syndrome with diarrhea and improves quality of life in women Gastroenterology 150 2016 358 366.e8
77. M. Thabane, D.T. Kottachchi, and J.K. Marshall Systematic review and meta-analysis: The incidence and prognosis of post-infectious irritable bowel syndrome Aliment Pharmacol Ther 26 2007 535 544
78. R. Spiller, and K. Garsed Postinfectious irritable bowel syndrome Gastroenterology 136 2009 1979 1988
79. C. Cremon, V. Stanghellini, F. Pallotti, and et al. Salmonella gastroenteritis during childhood is a risk factor for irritable bowel syndrome in adulthood Gastroenterology 147 2014 69 77
80. C. Swan, N.P. Duroudier, E. Campbell, and et al. Identifying and testing candidate genetic polymorphisms in the irritable bowel syndrome (IBS): association with TNFSF15 and TNFalpha Gut 62 2013 985 994
81. G. Barbara, C. Cremon, G. Carini, and et al. The immune system in irritable bowel syndrome J Neurogastroenterol Motil 17 2011 349 359
82. M.M. Walker, S.S. Salehian, C.E. Murray, and et al. Implications of eosinophilia in the normal duodenal biopsy - an association with allergy and functional dyspepsia Aliment Pharmacol Ther 31 2010 1229 1236
83. H. Vanheel, M. Vicario, T. Vanuytsel, and et al. Impaired duodenal mucosal integrity and low-grade inflammation in functional dyspepsia Gut 63 2014 262 271
84. H. Lee, H. Chung, J.C. Park, and et al. Heterogeneity of mucosal mast cell infiltration in subgroups of patients with esophageal chest pain Neurogastroenterol Motil 26 2014 786 793
85. C. Cremon, L. Gargano, A.M. Morselli-Labate, and et al. Mucosal immune activation in irritable bowel syndrome: gender-dependence and association with digestive symptoms Am J Gastroenterol 104 2009 392 400
86. L. Belmonte, S. Beutheu Youmba, N. Bertiaux-Vandaele, and et al. Role of toll like receptors in irritable bowel syndrome: differential mucosal immune activation according to the disease subtype PLoS One 7 2012 e42777
87. Y. Nasser, G.E. Boeckxstaens, M.M. Wouters, and et al. Using human intestinal biopsies to study the pathogenesis of irritable bowel syndrome Neurogastroenterol Motil 26 2014 455 469
88. I. Barajon, G. Serrao, F. Arnaboldi, and et al. Toll-like receptors 3, 4, and 7 are expressed in the enteric nervous system and dorsal root ganglia J Histochem Cytochem 57 2009 1013 1023
89. C. Rumio, D. Besusso, F. Arnaboldi, and et al. Activation of smooth muscle and myenteric plexus cells of jejunum via Toll-like receptor 4 J Cell Physiol 208 2006 47 54
90. E.K. Brint, J. MacSharry, A. Fanning, and et al. Differential expression of toll-like receptors in patients with irritable bowel syndrome Am J Gastroenterol 106 2011 329 336
91. L. Bueno Protease activated receptor 2: a new target for IBS treatment Eur Rev Med Pharmacol Sci 12 Suppl 1 2008 95 102
92. N. Steck, K. Mueller, M. Schemann, and et al. Bacterial proteases in IBD and IBS Gut 61 2012 1610 1618
93. E.E. Valdez-Morales, J. Overington, R. Guerrero-Alba, and et al. Sensitization of peripheral sensory nerves by mediators from colonic biopsies of diarrhea-predominant irritable bowel syndrome patients: a role for PAR2 Am J Gastroenterol 108 2013 1634 1643
94. N. Cenac, C.N. Andrews, M. Holzhausen, and et al. Role for protease activity in visceral pain in irritable bowel syndrome J Clin Invest 117 2007 636 647
95. G. Barbara, B. Wang, V. Stanghellini, and et al. Mast cell-dependent excitation of visceral-nociceptive sensory neurons in irritable bowel syndrome Gastroenterology 132 2007 26 37
96. S. Buhner, Q. Li, S. Vignali, and et al. Activation of human enteric neurons by supernatants of colonic biopsy specimens from patients with irritable bowel syndrome Gastroenterology 137 2009 1425 1434
97. G. Dothel, M.R. Barbaro, H. Boudin, and et al. Nerve fiber outgrowth is increased in the intestinal mucosa of patients with irritable bowel syndrome Gastroenterology 148 2015 1002 1011 e4
98. L. O'Mahony, J. McCarthy, P. Kelly, and et al. Lactobacillus and bifidobacterium in irritable bowel syndrome: symptom responses and relationship to cytokine profiles Gastroenterology 128 2005 54 551
99. L. Ohman, S. Isaksson, A.C. Lindmark, and et al. T-cell activation in patients with irritable bowel syndrome Am J Gastroenterol 104 2009 1205 1212
100. G. Barbara, V. Stanghellini, R. De Giorgio, and et al. Activated mast cells in proximity to colonic nerves correlate with abdominal pain in irritable bowel syndrome Gastroenterology 126 2004 693 702
101. T. Liebregts, B. Adam, C. Bredack, and et al. Small bowel homing T cells are associated with symptoms and delayed gastric emptying in functional dyspepsia Am J Gastroenterol 106 2011 1089 1098
102. M.I. Park, and M. Camilleri Is there a role of food allergy in irritable bowel syndrome and functional dyspepsia? A systematic review Neurogastroenterol Motil 18 2006 595 607
103. A. Fritscher-Ravens, D. Schuppan, M. Ellrichmann, and et al. Confocal endomicroscopy shows food-associated changes in the intestinal mucosa of patients with irritable bowel syndrome Gastroenterology 147 2014 1012 1020 e4
104. E. Gudmand-Hoyer, P. Riis, and H.R. Wulff The significance of lactose malabsorption in the irritable colon syndrome Scand J Gastroenterol 8 1973 273 278
105. Y.K. Choi, N. Kraft, B. Zimmerman, and et al. Fructose intolerance in IBS and utility of fructose-restricted diet J Clin Gastroenterol 42 2008 233 238
106. J.J. Rumessen, and E. Gudmand-Hoyer Functional bowel disease: the role of fructose and sorbitol Gastroenterology 101 1991 1452 1453
107. A.C. Ford, W.D. Chey, N.J. Talley, and et al. Yield of diagnostic tests for celiac disease in individuals with symptoms suggestive of irritable bowel syndrome: systematic review and meta-analysis Arch Intern Med 169 2009 651 658
108. B.D. Cash, J.H. Rubenstein, P.E. Young, and et al. The prevalence of celiac disease among patients with nonconstipated irritable bowel syndrome is similar to controls Gastroenterology 141 2011 1187 1193
109. J.F. Ludvigsson, D.A. Leffler, J.C. Bai, and et al. The Oslo definitions for coeliac disease and related terms Gut 62 2013 43 52
110. A.C. Ford, B.M. Spiegel, N.J. Talley, and et al. Small intestinal bacterial overgrowth in irritable bowel syndrome: systematic review and meta-analysis Clin Gastroenterol Hepatol 7 2009 1279 1286
111. B.M. Spiegel Questioning the bacterial overgrowth hypothesis of irritable bowel syndrome: an epidemiologic and evolutionary perspective Clin Gastroenterol Hepatol 9 2011 461 469 quiz e59
112. A. Shin, M. Camilleri, P. Vijayvargiya, and et al. Bowel functions, fecal unconjugated primary and secondary bile acids, and colonic transit in patients with irritable bowel syndrome Clin Gastroenterol Hepatol 11 2013 1270 1275 e1
113. J.R. Walters, A.M. Tasleem, O.S. Omer, and et al. A new mechanism for bile acid diarrhea: defective feedback inhibition of bile acid biosynthesis Clin Gastroenterol Hepatol 7 2009 1189 1194
114. M. Camilleri, K. Lasch, and W. Zhou Irritable bowel syndrome: methods, mechanisms, and pathophysiology. The confluence of increased permeability, inflammation, and pain in irritable bowel syndrome Am J Physiol Gastrointest Liver Physiol 303 2012 G775 G785
115. K. Garsed, J. Chernova, M. Hastings, and et al. A randomised trial of ondansetron for the treatment of irritable bowel syndrome with diarrhoea Gut 63 2014 1617 1625
116. P.A. Hughes, H. Zola, I.A. Penttila, and et al. Immune activation in irritable bowel syndrome: can neuroimmune interactions explain symptoms? Am J Gastroenterol 108 2013 1061 1074
117. G. Barbara, C. Cremon, V. Annese, and et al. Randomised controlled trial of mesalazine in IBS Gut 65 2016 82 90
118. C. Lam, W. Tan, M. Leighton, and et al. A mechanistic multicentre, parallel group, randomised placebo-controlled trial of mesalazine for the treatment of IBS with diarrhoea (IBS-D) Gut 65 2016 91 99
119. A.B. Sahakian, S.R. Jee, and M. Pimentel Methane and the gastrointestinal tract Dig Dis Sci 55 2010 2135 2143
120. S.I. Sayin, A. Wahlstrom, J. Felin, and et al. Gut microbiota regulates bile acid metabolism by reducing the levels of tauro-beta-muricholic acid, a naturally occurring FXR antagonist Cell Metab 17 2013 225 235